A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Im...
A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome
About this item
Full title
Author / Creator
the AIDS Clinical Trials Group , Fischl, Margaret A , Parker, Corette B , Pettinelli, Carla , Wulfsohn, Michael , Hirsch, Martin S , Collier, Ann C , Antoniskis, Diana , Ho, Monto , Richman, Douglas D , Fuchs, Edward , Merigan, Thomas C , Reichman, Richard C , Gold, Jonathan , Steigbigel, Neal , Leoung, Gifford S , Rasheed, Suraiya and Tsiatis, Anastasios
Publisher
Boston, MA: Massachusetts Medical Society
Journal title
Language
English
Formats
Publication information
Publisher
Boston, MA: Massachusetts Medical Society
Subjects
More information
Scope and Contents
Contents
ZIDOVUDINE (3′-azido-3′-deoxythymidine; formerly azidothymidine, or AZT) is a thymidine analogue that inhibits the replication of the human immunodeficiency virus type 1 (HIV) in vitro.
1
The administration of zidovudine to patients with advanced HIV disease over a 6-to-24-month period prolongs survival, decreases the frequency and severity o...
Alternative Titles
Full title
A Randomized Controlled Trial of a Reduced Daily Dose of Zidovudine in Patients with the Acquired Immunodeficiency Syndrome
Authors, Artists and Contributors
Author / Creator
Fischl, Margaret A
Parker, Corette B
Pettinelli, Carla
Wulfsohn, Michael
Hirsch, Martin S
Collier, Ann C
Antoniskis, Diana
Ho, Monto
Richman, Douglas D
Fuchs, Edward
Merigan, Thomas C
Reichman, Richard C
Gold, Jonathan
Steigbigel, Neal
Leoung, Gifford S
Rasheed, Suraiya
Tsiatis, Anastasios
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_15794181
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_15794181
Other Identifiers
ISSN
0028-4793
E-ISSN
1533-4406
DOI
10.1056/NEJM199010113231501
